Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|June 27, 2013
Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillationWinnie W Nelson, Jiyoon C Choi, Julie Vanderpoel, et al.
Current Medical Research and Opinion|June 14, 2014
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillationWinnie W Nelson, Xue Song, Craig I Coleman, et al.
Drugs & Aging|March 31, 2025
Benefit-Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous ThromboembolismPaul P Dobesh, Albert A Volkl, Ákos Ferenc Pap, et al.
Blood Advances|November 22, 2021
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINIAlok A Khorana, John Barnard, Ted Wun, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromesMary Ann Mascelli, Efthymios N Deliargyris, Lakshmi V Damaraju, et al.
Journal of Occupational and Environmental Medicine|June 22, 2013
The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costsRobert L Page, Vahram Ghushchyan, Brian Gifford, et al.
Current Medical Research and Opinion|October 10, 2013
Risk factors associated with myocardial infarction in venous thromboembolism patientsF Laliberté, E A Nutescu, P Lefebvre, et al.
Current Medical Research and Opinion|March 22, 2014
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patientsFrançois Laliberté, Michel Cloutier, Winnie W Nelson, et al.
Pageof 6